No problem Northstar, we all new what you meant an

No problem Northstar, we all new what you meant and your are absolutely correct in saying that with the development of an assay that can reliably determine a patient’s CCR5 status is huge by all means. I also believe that this is contributing to the rise in shares today. Will it hold? That remains to be seen since it could be very possible that it can be sold down for those wanting it down and we all know who they are - GLTU

HCIT

https://media.gettyimages.com/photos/the-grea...wdoE_swYM=